Description |
6-Hydroxyrubiadin, a natural anthraquinone, may be a potential therapeutic candidate for the treatment of inflammation and inflammatory diseases[1].
|
In Vitro |
6-hydroxyrubiadin suppresses lipopolysaccharide (LPS)-induced nuclear factor-kappa B activation as well as the phosphorylation of c-Jun N-terminal kinase in RAW 264.7 macrophages[1]. 6-hydroxyrubiadin inhibited the expression of tumor necrosis factor (TNF)-a, interleukin (IL)-1b and IL-6 in phorbol myristate acetate (PMA)-primed U937 and RAW 264.7cells[1].
|
In Vivo |
6-hydroxyrubiadin can reduce the production of pro-inflammatory cytokines and ameliorate acute lung injury (ALI) in a mouse model[1].
|
Density | 1.6±0.1 g/cm3 |
Boiling Point | 558.7±19.0 °C at 760 mmHg |
Flash Point | 305.7±18.0 °C |
Exact Mass | 270.052826 |
PSA | 94.83000 |
LogP | 4.42 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |